Literature DB >> 20561572

Solid-state transformation of different gabapentin polymorphs upon milling and co-milling.

Shan-Yang Lin1, Cheng-Hung Hsu, Wen-Ting Ke.   

Abstract

The purpose of this study was to investigate the milling effect on the polymorphic transformation of four gabapentin (GBP) Forms I-IV in the absence of additive. Four polymorphs of GBP were previously prepared and identified, in which the GBP Form I was proven to be a monohydrate, but other GBP Forms II-IV belonged to anhydrate. The GBP Form II was the most stable polymorph available in the market. The co-milling process affecting the polymorphic stability of GBP Form II with different additives was also examined. During the 120-min-milling or co-milling course, the milled sample was withdrawn at prescribed intervals for Fourier transform infrared (FTIR) microspectroscopic determination. In the absence of additive, each polymorph of GBP exhibits a different polymorphic transformation behavior in the 120-min-milling course. The results indicate that GBP Form I was previously dehydrated and transited to Form II; GBP Form II was first transformed to Form III and then changed to Form IV; GBP Form III was previously transited to Form II, then changed to Form III and transformed to Form IV at last; whereas GBP Form IV was first changed to Form II, then transited to Form III and finally to Form IV. It was clearly evidenced that if GBP Form III or IV appeared in the milled mixture a little amount of GBP-lactam was certainly detected. In the presence of additives, there was almost lack of polymorphic transition for GBP Form II by co-milling GBP Form II with Emcompress, beta-cyclodextrin, mannitol, corn starch or magnesium stearate. By co-milling GBP Form II with Avicel, dextrin, hydroxypropyl beta-cyclodextrin, hydroxypropyl methylcellulose, Kollidon K-30 or gelatin, GBP Form II was transformed to Form IV alone. On the other hand, the GBP Form IV and a little amount of GBP-lactam were also found in the co-milled mixture after co-milling with GBP Form II with Aerosil or talc. This reveals that the solid-state transformation of GBP Form II after co-milling was markedly dependent on the types of additive used. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561572     DOI: 10.1016/j.ijpharm.2010.06.014

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.

Authors:  Niraj S Trasi; Stephen R Byrn
Journal:  AAPS PharmSciTech       Date:  2012-05-15       Impact factor: 3.246

2.  The stabilizing effect of moisture on the solid-state degradation of gabapentin.

Authors:  Zhixin Zong; Salil D Desai; Aditya M Kaushal; Dewey H Barich; Hong-Shian Huang; Eric J Munson; Raj Suryanarayanan; Lee E Kirsch
Journal:  AAPS PharmSciTech       Date:  2011-07-09       Impact factor: 3.246

3.  Investigation of Quantitative X-ray Microscopy for Assessment of API and Excipient Microstructure Evolution in Solid Dosage Processing.

Authors:  Aiden Zhu; Chen Mao; Paul E Luner; Joshua Lomeo; Chi So; Stephanie Marchal; Shawn Zhang
Journal:  AAPS PharmSciTech       Date:  2022-04-19       Impact factor: 3.246

4.  Polymorphic and Covalent Transformations of Gabapentin in Binary Excipient Mixtures after Milling-Induced Stress.

Authors:  Radaduen Tinmanee; Stephen D Stamatis; Eji Ueyama; Kenneth R Morris; Lee E Kirsch
Journal:  Pharm Res       Date:  2018-02-01       Impact factor: 4.200

5.  Investigating gabapentin polymorphism using solid-state NMR spectroscopy.

Authors:  Kassibla E Dempah; Dewey H Barich; Aditya M Kaushal; Zhixin Zong; Salil D Desai; Raj Suryanarayanan; Lee Kirsch; Eric J Munson
Journal:  AAPS PharmSciTech       Date:  2012-11-22       Impact factor: 3.246

6.  The Analysis of the Physicochemical Properties of Benzocaine Polymorphs.

Authors:  Magdalena Paczkowska; Gabriela Wiergowska; Andrzej Miklaszewski; Anna Krause; Magdalena Mroczkowka; Przemysław Zalewski; Judyta Cielecka-Piontek
Journal:  Molecules       Date:  2018-07-16       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.